America is currently experiencing a national opioid epidemic, fueled by aggressive advertising from painkiller manufacturers. The conversation over the past few years has drastically shifted, with Federal institutions like the Center for Disease Control acknowledging that alternatives to opioid-based pain relief could alleviate our nation’s addiction.
The most promising of the opioid alternatives is, you guessed it, cannabis. Recent data shows that states with medical cannabis laws have drastically fewer opioid prescriptions per capita, as well as significantly fewer opioid overdoses each year. Still, cannabis is facing a major uphill battle, with deep-pocketed pharmaceutical companies spending large amounts of money to fight cannabis legalization.
Enter HelloMD, a service that connects would-be medical cannabis patients with doctors who can grant recommendations through online consultations. HelloMD is one of Yerba’s favorite partners to work with, so when we heard they are teaming up with UC Berkeley to conduct the largest cannabis patient survey, we thought we should spread the good news.
How the Study Will Work
The University of California at Berkeley has been comfortable approaching cannabis data for much longer than other national universities. So they were the perfect academic organization for HelloMD to partner alongside. The study will be conducted by Amanda Reiman, who is both a UC lecturer as well as a manager for the Drug Policy Alliance, along with medical PhDs from Kent State University and the University of Northern Florida.
The key to the study (besides having wonderful medical analysts) is the willing participation from cannabis patients who want to share their successful cannabis experiences with health professionals. HelloMD has a database with nearly 100,000 potential respondents for the survey. When it comes to data analysis, especially in medical fields, it is extremely important for researchers to have access to thousands of data points.
Past cannabis surveys are consistently dismissed by medical professionals for not providing a large enough pool of responses. The issue here is that a survey with responses in the hundreds can reveal misleading conclusions. On the other hand, a survey with thousands and thousands of responses will eliminate the significance of outlier responses, and show results that more accurately reflect the effects of cannabis on human health.
This HelloMD survey is a follow-up to the January 2016 survey “Medical Marijuana Patient Survey Results,” which reviewed responses from over 1,400 patients. Please email us at firstname.lastname@example.org if you are interested in participating in the HelloMD survey!
Yerba takes great pride in building a responsible cannabis community. We encourage you to follow us on Facebook, Twitter, and Instagram to keep up to date on all of the information and opportunities we offer.
And of course, you can explore the cannabis available at Yerba.org!